The Latin America, Middle East and Africa Synthetic Small Molecule API Market would witness market growth of 7.7% CAGR during the forecast period (2022-2028).
Participants, managers, and observers in the bio/pharmaceutical business have generally agreed that the concentration on biologics has made small-molecule medications outdated. Reports of the demise of small-molecule medications are highly overstated, to paraphrase what Mark Twain purportedly said of his circumstance. 60% of all new molecular entities and 82% of all new drug application (NDA) approvals in 2014 were for small-molecule medicines.
Additionally, they make up two-thirds of the pipeline for developing new drugs. Small-molecule medications represent a significant and highly effective part of the bio/pharmaceutical portfolio, even though there is little question that the number and share of large-molecule treatments are rising. Many of the most significant medications released in recent years, including kinase inhibitors like Gleevec and anti-retroviral medications such Sovaldi, are small molecules.
Compared to large molecules, small molecules have several important advantages. At modest doses, often below 10 mg and even in the microgram range, they can be produced to have strong therapeutic benefits. When compared to large-molecule therapies, smaller volumes of API and advanced chemical manufacturing techniques often translate into a cheaper cost of goods. Small molecule analytical technology is highly developed, ensuring quality, effectiveness, and reproducibility.
Research by the WHO indicates that 7% of the world's population is genetically predisposed to hemoglobin diseases such as sickle cell disease and thalassemia. The LAMEA region is experiencing an increase in the need for molecular quality controls as a result of the rising prevalence of such genetic diseases. The government's programs to support clinical research serve as a significant economic engine for the Molecular Quality Control sector. Due to a growth in QC molecular labs, the market for molecular control has grown in the area. In the following years, it is anticipated that in this region, which are both developing, will recover from the consequences of COVID-19 which will surge the growth of the synthetic small molecule API market.
The Brazil market dominated the LAMEA Synthetic Small Molecule API Market by Country in 2021; thereby, achieving a market value of $2,903 million by 2028. The Argentina market would showcase a CAGR of 8.2% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 7.4% during (2022 - 2028).
Based on Manufacturer, the market is segmented into In-house and Outsourced. Based on Application, the market is segmented into Cardiology, Oncology, CNS & Neurology, Endocrinology, Orthopedic, Gastroenterology, Pulmonology, Nephrology, Ophthalmology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Synthetic Small Molecule API Market is Predict to reach $187.8 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Viatris, Inc., Cipla Limited, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceuticals Industries Ltd., AbbVie, Inc., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Aurobindo Pharma Limited and Albermale Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Manufacturer
By Application
- Cardiology
- Oncology
- CNS & Neurology
- Endocrinology
- Orthopedic
- Gastroenterology
- Pulmonology
- Nephrology
- Ophthalmology
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Merck & Co., Inc.
- Viatris, Inc.
- Cipla Limited
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceuticals Industries Ltd.
- AbbVie, Inc.
- Bristol Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Aurobindo Pharma Limited
- Albermale Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Synthetic Small Molecule API Market, by Manufacturer
1.4.2 LAMEA Synthetic Small Molecule API Market, by Application
1.4.3 LAMEA Synthetic Small Molecule API Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Synthetic Small Molecule API Market by Manufacturer
3.1 LAMEA In-house Market by Country
3.2 LAMEA Outsourced Market by Country
Chapter 4. LAMEA Synthetic Small Molecule API Market by Application
4.1 LAMEA Cardiology Market by Country
4.2 LAMEA Oncology Market by Country
4.3 LAMEA CNS & Neurology Market by Country
4.4 LAMEA Endocrinology Market by Country
4.5 LAMEA Orthopedic Market by Country
4.6 LAMEA Gastroenterology Market by Country
4.7 LAMEA Pulmonology Market by Country
4.8 LAMEA Nephrology Market by Country
4.9 LAMEA Ophthalmology Market by Country
4.1 LAMEA Others Market by Country
Chapter 5. LAMEA Synthetic Small Molecule API Market by Country
5.1 Brazil Synthetic Small Molecule API Market
5.1.1 Brazil Synthetic Small Molecule API Market by Manufacturer
5.1.2 Brazil Synthetic Small Molecule API Market by Application
5.2 Argentina Synthetic Small Molecule API Market
5.2.1 Argentina Synthetic Small Molecule API Market by Manufacturer
5.2.2 Argentina Synthetic Small Molecule API Market by Application
5.3 UAE Synthetic Small Molecule API Market
5.3.1 UAE Synthetic Small Molecule API Market by Manufacturer
5.3.2 UAE Synthetic Small Molecule API Market by Application
5.4 Saudi Arabia Synthetic Small Molecule API Market
5.4.1 Saudi Arabia Synthetic Small Molecule API Market by Manufacturer
5.4.2 Saudi Arabia Synthetic Small Molecule API Market by Application
5.5 South Africa Synthetic Small Molecule API Market
5.5.1 South Africa Synthetic Small Molecule API Market by Manufacturer
5.5.2 South Africa Synthetic Small Molecule API Market by Application
5.6 Nigeria Synthetic Small Molecule API Market
5.6.1 Nigeria Synthetic Small Molecule API Market by Manufacturer
5.6.2 Nigeria Synthetic Small Molecule API Market by Application
5.7 Rest of LAMEA Synthetic Small Molecule API Market
5.7.1 Rest of LAMEA Synthetic Small Molecule API Market by Manufacturer
5.7.2 Rest of LAMEA Synthetic Small Molecule API Market by Application
Chapter 6. Company Profiles
6.1 Merck & Co., Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.2 Viatris, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cipla Limited
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Teva Pharmaceutical Industries Ltd.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Sun Pharmaceuticals Industries Ltd.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Bristol Myers Squibb Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Boehringer Ingelheim International Gmbh
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional & Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Aurobindo Pharma Limited
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Albemarle Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental Analysis
6.10.4 Research & Development Expenses
TABLE 1 LAMEA Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 4 LAMEA Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 5 LAMEA In-house Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA In-house Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 10 LAMEA Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 11 LAMEA Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Oncology Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Oncology Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA CNS & Neurology Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA CNS & Neurology Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Endocrinology Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Endocrinology Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Orthopedic Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Orthopedic Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Gastroenterology Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Gastroenterology Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Pulmonology Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Pulmonology Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Nephrology Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Nephrology Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Ophthalmology Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Ophthalmology Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Synthetic Small Molecule API Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Synthetic Small Molecule API Market by Country, 2022 - 2028, USD Million
TABLE 33 Brazil Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 34 Brazil Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 35 Brazil Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 36 Brazil Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 37 Brazil Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 38 Brazil Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 39 Argentina Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 40 Argentina Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 41 Argentina Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 42 Argentina Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 43 Argentina Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 44 Argentina Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 45 UAE Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 46 UAE Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 47 UAE Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 48 UAE Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 49 UAE Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 50 UAE Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 51 Saudi Arabia Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 52 Saudi Arabia Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 57 South Africa Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 58 South Africa Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 59 South Africa Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 60 South Africa Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 61 South Africa Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 62 South Africa Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 63 Nigeria Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 64 Nigeria Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 65 Nigeria Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 66 Nigeria Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 67 Nigeria Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 68 Nigeria Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 69 Rest of LAMEA Synthetic Small Molecule API Market, 2018 - 2021, USD Million
TABLE 70 Rest of LAMEA Synthetic Small Molecule API Market, 2022 - 2028, USD Million
TABLE 71 Rest of LAMEA Synthetic Small Molecule API Market by Manufacturer, 2018 - 2021, USD Million
TABLE 72 Rest of LAMEA Synthetic Small Molecule API Market by Manufacturer, 2022 - 2028, USD Million
TABLE 73 Rest of LAMEA Synthetic Small Molecule API Market by Application, 2018 - 2021, USD Million
TABLE 74 Rest of LAMEA Synthetic Small Molecule API Market by Application, 2022 - 2028, USD Million
TABLE 75 KEY INFORMATION - MERCK & CO., INC.
TABLE 76 key information – Viatris, Inc.
TABLE 77 Key Information – Cipla Limited
TABLE 78 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 80 Key information – AbbVie, Inc.
TABLE 81 Key Information – Bristol Myers Squibb Company
TABLE 82 Key Information – Boehringer Ingelheim International GmbH
TABLE 83 key information – Aurobindo Pharma Limited
TABLE 84 Key Information – Albemarle Corporation
List of Figures
FIG 1 Methodology for the research